Skip to content

HRSA Health Resources & Services Administration

Table ODE: Other Data Elements

National Data

1,370 Awardees

Measures Number of Physicians (1a) or Patients (1b) % of Total
1. Medication-Assisted Treatment (MAT) for Opioid Use Disorder
1a. How many physicians, certified nurse practitioners, physician assistants, and certified nurse midwives, on-site or with whom the health center has contracts, have a Drug Addiction Treatment Act of 2000 (DATA) waiver to treat opioid use disorder with medications specifically approved by the U.S. Food and Drug Administration (FDA) (i.e., buprenorphine) for that indication during the calendar year? 10,331
1b. During the calendar year, how many patients received MAT for opioid use disorder from a physician, certified nurse practitioner, physician assistant, or certified nurse midwife with a DATA waiver working on behalf of the health center? 193,986 0.64%
Measures Number of Health centers % of Total
2. Did your organization use telemedicine to provide remote (virtual) clinical care services? The term telehealth includes telemedicine services, but encompasses a broader scope of remote health care services. Telemedicine is specific to remote clinical services, whereas telehealth may include remote non-clinical services, such as provider training, administrative meetings, and continuing medical education, in addition to clinical services.
a. Yes 1,358 99.12%
b. No 12 0.88%
2a1. Who did you use telemedicine to communicate with? (Select all that apply.)
a. Patients at remote locations from your organization (e.g., home telehealth, satellite locations) 1,346 99.12%
b. Specialists outside your organization (e.g., specialists at referral centers) 270 19.88%
2a2. What telehealth technologies did you use? (Select all that apply.)
a. Real-time telehealth (e.g., live videoconferencing) 1,341 98.75%
b. Store-and-forward telehealth (e.g., secure email with photos or videos of patient examinations) 194 14.29%
c. Remote patient monitoring 435 32.03%
d. Mobile Health (mHealth) 111 8.17%
2a3. What primary telemedicine services were used at your organization? (Select all that apply.)
a. Primary Care 1,324 97.50%
b. Oral Health 189 13.92%
c. Behavioral Health: Mental Health 1,283 94.48%
d. Behavioral Health: Substance Use Disorder 860 63.33%
e. Dermatology 99 7.29%
f. Chronic Conditions 867 63.84%
g. Disaster Management 47 3.46%
h. Consumer health education 261 19.22%
i. Provider to provider consultation 224 16.49%
j. Radiology 57 4.20%
k. Nutrition and dietary counseling 524 38.59%
l. Other 114 8.39%
2b. If you did not have telemedicine services, please comment why (Select all that apply.)
a. Have not considered/unfamiliar with telehealth service options 0 0.00%
b. Policy barriers (Select all that apply) 0 0.00%
c. Inadequate broadband/telecommunication service (Select all that apply) 4 33.33%
ci. Cost of Service 1 8.33%
cii. Lack of Infrastructure 4 33.33%
ciii. Other 0 0.00%
d. Lack of funding for telehealth equipment 1 8.33%
e. Lack of training for telehealth services 2 16.67%
f. Not needed 5 41.67%
g. Other 3 25.00%
Line Measures Number of Assist *
3. Provide the number of all assists provided during the past year by all trained assisters (e.g., certified application counselor or equivalent) working on behalf of the health center (personnel, contracted personnel, or volunteers), regardless of the funding source that is supporting the assisters' activities. Outreach and enrollment assists are defined as customizable education sessions about third-party primary care health insurance coverage options (one-on-one or small group) and any other assistance provided by a health center assister to facilitate enrollment. 4,020,609


'-' Data cannot be calculated or has been suppressed for confidentiality purposes.

Cells that are shaded blue represent data that was not reported or null values.

The number of providers with a Drug Addiction Treatment Act of 2000 (DATA) waiver for MAT in 2021 was incorrectly reported as 16,769 and should be 8,869 under Line 1a of Table ODE: Other Data Elements. The source of the error was identified to be isolated to a data entry error by one health center and has been corrected in this report.

View Detailed UDS Footnotes

Accessibility Statement:
Persons using assistive technology may not be able to fully access information in these files. For assistance, contact the Health Center Program Support at: 877-464-4772.